Clik here to view.
OliX Pharmaceuticals Identifies Effective Inhibition of Target Gene...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company identified effective inhibition of target gene expression...
View ArticleClik here to view.
武田薬品工業：2021年度は力強い業績を達成、2022年度も成長の勢いは継続の見込み
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TOKYO：4502/NYSE:TAK）は、本日、2021年度の業績を公表しましたのでお知らせします。成長製品の伸長、新製品の上市ならびに主要なビジネス領域全体での成長が牽引し、力強い業績を達成しました。 当社代表取締役社長CEOのクリストフ・ウェバー（Christophe Weber）は次のように述べています。...
View ArticleClik here to view.
Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in...
OSAKA, Japan Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for fiscal year 2021 (period ended March 31, 2022), driven by the performance of its growth products, new product...
View ArticleClik here to view.
Propanc Biopharma Offers a Novel Way to Stop Cancer
MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
武田实现强劲的2021财年业绩；预计增长势头将在2022财年持续
日本大阪 (美国商业资讯)–武田(Takeda, TOKYO:4502/NYSE:TAK)今天公布了强劲的2021财年业绩（截至2022年3月21日的期间）。该业绩得益于公司增长型产品的表现、新产品的推出以及在其关键业务领域的实力。 武田总裁兼首席执行官Christophe...
View ArticleClik here to view.
CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading China-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
Clik here to view.
KAUST孵化五家国际尖端初创企业，为沙特阿拉伯带来新科技
沙特阿拉伯图沃 (美国商业资讯)–阿卜杜拉国王科技大学(KAUST)最近圆满完成了沙特阿拉伯优先计划“Destination Deep Tech”。该计划旨在孵化国际尖端初创企业前往沙特阿拉伯进行深度科技创新。国际初创企业CeEntek、Hopu、Insignes-Labs、Pasqal和Proteinea因其在中东和北非地区高精尖技术的扩张而获选参与这个为期三个月的计划。...
View ArticleClik here to view.
Emendo Biotherapeutics’ next generation CRISPR gene editing technologies...
NEW YORK Emendo Biotherapeutics presented the results of its next generation CRISPR-based gene editing approaches for several indications in an oral presentation and three posters at the 25th Annual...
View ArticleClik here to view.
LUCA Science and Kyowa Kirin Announce Joint Research Agreement on...
TOKYO LUCA Science Inc. (LUCA Science, Tokyo, Japan) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, Tokyo, Japan, TSE:4151) are pleased to announce they have entered into a research collaboration agreement...
View ArticleClik here to view.
On Gout Awareness Day, Let’s Put the Myths to Rest
JIANGSU, China Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for metabolic and inflammatory diseases, such...
View ArticleClik here to view.
Propanc Biopharma Undertaking PRP Manufacturing ＆ Development for Human Use
MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
エメンド・バイオセラピューティクスが次世代CRISPR遺伝子編集技術のアレル特異的手法によりELANE関連重症先天性好中球減少症の治療で達成した画期的成果...
ニューヨーク （ビジネスワイヤ） — エメンド・バイオセラピューティクスは、2022年5月16～19日にワシントンDCで開催された米国遺伝子細胞治療学会（ASGCT）の第25回年次総会において、複数の適応症に対するCRISPRベースの次世代型遺伝子編集手法の結果を、1件の口頭発表と3件のポスター発表で報告しました。...
View ArticleClik here to view.
Genuv Announces Preclinical Data to be Released at Two Medical Conferences in...
SEOUL, South Korea Genuv Inc., a clinical-stage biotechnology company focused on innovative drug discovery for degenerative central nervous system diseases and advanced immuno-oncology therapeutics,...
View ArticleClik here to view.
Embleema and CDISC Partner to Develop Standards for Cell and Gene Therapy...
METUCHEN, N.J. & AUSTIN, Texas Embleema Inc. and CDISC have announced a collaboration to develop new standards for experimental assays and bioinformatics protocols to facilitate monitoring the...
View ArticleClik here to view.
BGI Releases 1st Panoramic Atlases of Life
SHENZHEN, China International scientists led by China’s BGI•Research released the world’s first panoramic spatial atlases of life on May 4, examining the cellular dynamics of organisms at different...
View ArticleClik here to view.
LUCA Science Raises ¥3.86 Billion ($30.3 Million) in Oversubscribed Series B...
TOKYO LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutical agents, today announced the closing of a ¥3.86 billion (USD 30.3 million) oversubscribed...
View ArticleClik here to view.
Parse Biosciences Announces Partnership with Molecular Diagnostics Korea
SEATTLE Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, today announced a partnership with Molecular Diagnostics Korea (MDxK) that will expand its presence in...
View ArticleClik here to view.
The Lancet Publication Shows Benefits of PharmaJet Needle-free delivery for...
GOLDEN, Colo. PharmaJet®, a biotech company that has developed a more effective way of administering drugs and biologics with their innovative, needle-free injection technology, today announced that...
View ArticleClik here to view.
パース・バイオサイエンシズがモレキュラー・ダイアグノスティクス・コリアとの提携を発表
シアトル （ビジネスワイヤ） — 拡張性のあるシングルセルシーケンシングソリューションを提供する一流企業であるパース・バイオサイエンシズは本日、モレキュラー・ダイアグノスティクス・コリア（MDxK）と提携したと発表しました。この提携では、韓国で当社のEvercode™ホールトランスクリプトーム製品群全体と細胞・核固定キットを提供することで、アジアでのプレゼンスを拡大していきます。...
View Article